Magenta Therapeutics Inc. (MGTA)
NASDAQ: MGTA
· Real-Time Price · USD
0.70
-0.06 (-7.69%)
At close: Sep 11, 2023, 10:00 PM
Magenta Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -85.92M | -56.41M | -27.36M | -68.69M | -82.68M | -76.46M | -75.58M | -76.94M | -76.6M | -71.14M | -70.01M | -70.26M | -72.41M |
Depreciation & Amortization | -429K | -562K | -87K | 1.36M | 1.14M | 1.93M | 1.99M | 2.06M | 2.76M | 2.02M | 1.98M | 1.94M | 1.96M |
Stock-Based Compensation | 23.58M | 18.26M | 8.47M | 4.19M | 5.62M | 7.02M | 7.44M | 9.73M | 10.02M | 10.31M | 10.46M | 9.02M | 9.39M |
Other Working Capital | -3.63M | -3.63M | -1.16M | 1.21M | 677K | -1.9M | -3.18M | -3.4M | -1.61M | -806K | -288K | 1.53M | -1.72M |
Other Non-Cash Items | -27.77M | -27.77M | -15.65M | 10.02M | 15.15M | 3.13M | 2.54M | 1.92M | 612K | 803K | 793K | 644K | 472K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 38.54M | 38.54M | 19.49M | -19.51M | -22.17M | -2.7M | -2.49M | -3.12M | 710K | -1.53M | -791K | 718K | -3.55M |
Operating Cash Flow | -55.57M | -27.94M | -15.14M | -72.64M | -82.95M | -67.09M | -66.09M | -66.35M | -62.5M | -59.53M | -57.57M | -57.94M | -64.14M |
Capital Expenditures | 443K | 467K | 171K | -559K | -688K | -470K | -329K | -1.3M | -1.28M | -1.26M | -1.46M | -351K | -276K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -757.35M | -690.02M | -295.86M | -39.15M | -79.27M | -109.61M | -145.14M | -125.54M | -85.42M | -45.31M | -90.76M | -90.76M | -90.76M |
Sales Maturities Of Investments | 126.14M | 44M | 7M | 110M | 95M | 60M | 70M | 52.5M | 82.5M | 90M | 75M | 77.5M | 62.5M |
Other Investing Acitivies | -10.92M | -10.92M | -1.51M | 5.54M | 41.78M | 40.27M | 40.12M | 40.12M | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -641.68M | -656.47M | -290.2M | 75.83M | 56.83M | -9.81M | -35.35M | -34.23M | -4.21M | 43.43M | -17.22M | -13.61M | -28.54M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -99.52M | -99.52M | n/a | 49.82M | 115K | 115K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 435.36M | 435.32M | 215.95M | 2.83M | 2.88M | 2.88M | 2.94M | 376K | 89.18M | 89.6M | 90.66M | 90.29M | 67.03M |
Financial Cash Flow | 372.26M | 372.1M | 166.24M | 2.83M | 2.88M | 2.88M | 2.94M | 376K | 89.18M | 89.6M | 90.66M | 90.29M | 67.03M |
Net Cash Flow | -81.02M | -68.34M | -16.4M | 6.02M | -23.24M | -74.02M | -98.51M | -100.2M | 22.48M | 73.5M | 15.86M | 18.75M | -25.64M |
Free Cash Flow | -55.13M | -27.48M | -14.97M | -73.2M | -83.64M | -67.56M | -66.42M | -67.65M | -63.78M | -60.8M | -59.04M | -58.29M | -64.42M |